Vivli is delighted to announce the launch of the Ambassador Program. The Ambassador Program aims to raise awareness of the importance of data sharing and data reuse, and of the research opportunities available in the Vivli data repository. Successful Vivli Ambassadors will be eligible for financial support to attend conferences in their area of research specialty. A total of five travel grants of $2,500 are available for successful applicants. Vivli Ambassadors will also participate in user interviews and testing twice a year to contribute to ongoing development of the Vivli platform.
Researchers who have successfully completed a research project using data from the Vivli repository are eligible to apply to become a Vivli Ambassador. Vivli will contact eligible researchers directly via email, with an invitation to submit a brief proposal outlining their idea for promoting research using the Vivli data repository.
If you have questions about this initiative or think you might be eligible to apply and haven’t received an email by April 1, 2025, please get in touch at support@vivli.org.
Vivli is pleased to announce the appointment of the new Chair to the Independent Review Panel (IRP). Dr. Sonali Kochhar, MD, will take on this role from 14th February 2025. Dr. Kochhar has already served as a member of the IRP for several years, bringing her wealth of expertise in Global Healthcare and clinical development.
Vivli CEO, Rebecca Li, PhD, welcomed Sonali as Chair, saying “We’re delighted to have Sonali take over as Chair of the IRP. Her experience and commitment will be invaluable going forward. ”
Vivli would also like to thank the longstanding IRP Chair, Jeff Koplan, who has served as Chair of the review panel since 2015.
“Jeff’s hard work and dedication in chairing the IRP for the last 10 years has been invaluable, and we wish him a happy retirement!” said Li.
Julie Wood, Vivli Chief Operating Officer, will join colleagues from Vivli and C-Path for a webinar on Thursday, February 20 at 12:00 pm ET. Julie will present an overview of Vivli’s global data-sharing and analytics platform and how Vivli’s collaboration with RDCA-DAP is advancing data sharing in rare diseases.
In addition to Julie’s presentation, the webinar will also include a panel discussion on platform-to-platform collaborations, strategies for facilitating data sharing, an interactive Q&A session with participants, and more!
Get more information and register today.
Vivli is pleased to announce that CEO Rebecca Li has been invited to speak at The Schaefer School of Engineering and Science (SES) at Stevens on Wednesday, October 16, 2024. She has been invited by Center for Global Clinical Research Data to speak as part of the Dean’s Distinguished Lecture Series, on the topic of “Driving Scientific Innovation Through Data Sharing.”
Li’s talk will examine the critical role of data sharing in fostering scientific progress and making well-informed decisions in clinical practice. She will draw on her 25 years of experience in the drug development process spanning the Biotech, Pharma, and NIH environments, as well as her work in founding and building the Vivli data repository over the past five years.
This in-person event will be open to all SES faculty, staff, students, alumni, and invited guests; information on attending is available here.
Vivli is pleased to announce that Rebecca Li will take part in an information session during the upcoming #SCDM24 Annual Conference. This event will take place in Boston September 29-October 2, 2024.
Li will participate in a session focusing on “nuts and bolts, best practices, and lessons learned on patient data sharing.” She will join colleagues Rebecca (Becky) Wilgus of the Duke Clinical Research Institute, Qiaoli (Lily) Chen of Pfizer, Jane Perlmutter of Gemini Group, and Marissa Stroo of the Duke University School of Medicine to share practical and applicable information that supports adoption of open data science, data sharing, and responsible data reuse from #clinical trials.
SCDM24 will bring leading experts in clinical data management together with the wider community.
Get complete information and register to join in person.
As Chief Technology Officer at Vivli, Robert Conklin is at the forefront of utilizing technological innovation to advance the state of clinical research. With over 25 years of experience in technology, Robert blends a deep understanding of scientific research with a approach to technological advancement.
In his role as CTO at Vivli, Robert leads the strategic direction for technology adoption and integration. His expertise spans a broad spectrum of areas, including data management, clinical trial automation, communication, and data security. He uses this expertise to further advance the Vivli platform, helping the world’s researchers to create new knowledge from the data that our members have shared.
Robert is passionate about leveraging emerging technologies to solve pressing challenges in clinical research to further the advancement of human knowledge. He has been instrumental in driving innovations that improve patient recruitment, streamline regulatory compliance, and ensure data integrity. His contributions have increased the speed, efficacy and safety of clinical trials at scale, and helped to create new knowledge.
Vivli’s CEO, Rebecca Li, will speak at the NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and Innovation. This online event, hosted by the National Institute of Diabetes and Digestive and Kidney Diseases, will take place on September 19-20, 2023.
Li will participate as a panelist in a discussion session on ‘Supporting NIDDK-Funded Research and Expanding NIDDK’s Data Ecosystem’. This session will focus on real-world examples in which NIDDK-funded research is strengthening the data ecosystem and accelerating medical breakthroughs through secondary research, and is scheduled to run on Wednesday, September 20. NIDDK has been making data available to researchers in the Vivli repository since 2022.
The 20th Anniversary Workshop will review the NIDDK Central Repository program from its early beginnings to its current state, and engage a diverse range of experts from the research community to share experiences and explore future possibilities. Registration is open until Tuesday, September 19 – find out more and register on the event website.
Vivli will host a workshop at the 2023 Cochrane Colloquium in London on September 4. The Cochrane Colloquium is an annual event for Cochrane in support of its mission to promote evidence-informed health decision-making.
Vivli’s workshop will focus on “Practical advice for accessing patient-level data from a data sharing platform for evidence synthesis.” This session will provide:
- an introduction to the Vivli platform, including an overview of data available and hands-on group work on how to submit a request for data
- an overview of first-hand experience of using patient level data using Vivli’s data sharing platform as a case study
- a discussion session focusing on some of the opportunities and challenges associated with using patient level data (for example: what to do when data needed to answer the hypothesis is not available via a single data sharing platform?)
This session will be a mixture of hands-on practice and opportunities to hear from researchers who have used the platform, patient advocates, and data providers. There will also be time for participants to ask questions about the data access process.
Vivli Senior Director Julie Wood will be joined by Alan Chant, the patient representative on the Independent Review Panel; Catrin Tudur Smith from the University of Liverpool; and Rebecca Sudlow from Roche to facilitate this workshop.
For more information on the 2023 Cochrane Colloquium and to register for this session, please see the event schedule. Please note that participation in this session is open only to registered Colloquium attendees.
Vivli Senior Advisor Azusa Tsukida spoke at Clinical Data Interchange Standards Consortium (CDISC) 2023 Japan Interchange Program on July 10.
Tsukida presented during the session on ‘Real World Data & Regulatory Presentations/Perspectives’. Her talk focused on the benefits of data sharing, using case studies from data contributors who are sharing high-quality data via the Vivli platform to enable access to researchers worldwide and contribute to scientific discovery.
CDISC works to develop and advance data standards to support transforming incompatible formats, inconsistent methodologies, and diverse perspectives into a coherent framework for generating clinical research data that is accessible, interoperable, and reusable. More than 80% of the data available in Vivli is formatted in the CDISC-SDTM standard.
Find out more about how you can request data from Vivli’s repository and help accelerate the progress of health research.
Vivli announced that its Board of Directors has promoted Rebecca Li to the position of CEO. Li previously held the position of Executive Director and has been with the Vivli since its founding when it launched as a project from the MRCT Center of the Brigham and Women’s Hospital and Harvard.
“Rebecca has overseen the extraordinary growth of Vivli from the start and we are excited that she will continue to lead Vivli through the next phase of growth as we aim to go even further in our mission to make clinical trial available for research. She has demonstrated herself to be an exceptional team leader and strategic thinker with a clear vision for how we will develop globally in the coming years,” said Dr. Michael Stebbins, Vivli’s Board Chair.
“I am privileged to lead Vivli and envision further expanding our successful platform technology into Europe and Asia as we enter our next phase of innovation and growth” said Dr. Rebecca Li.
Vivli was founded in 2018 as a non-profit organization that is currently the largest individual participant-level (IPD) data sharing platform focused on sharing clinical trial data serving the international research community.
